RESEARCH
13 Feb 2026
REGULATORY
12 Feb 2026
INNOVATION
11 Feb 2026
PARTNERSHIPS
10 Feb 2026

INVESTMENT
9 Feb 2026
SonoVascular’s $6M raise highlights rising interest in investigational ultrasound tools aimed at safer, more targeted clot treatment

PARTNERSHIPS
9 May 2025
Pharma firm PCI buys Althea site to boost US production of next-gen injectables like ADCs and mRNA therapies.

REGULATORY
2 May 2025
USP’s 2026 standards push pharma to modernize impurity testing

INSIGHTS
30 Apr 2025
Synthetic Design Lab launches SYNTHBODY to improve drug targeting for aggressive, treatment-resistant cancers

PARTNERSHIPS
11 Apr 2025
A Merck-Alteogen breakthrough could slash cancer treatment time to two minutes

RESEARCH
31 Mar 2025
MIT’s dissolvable implant could end the cycle of repeat injections with up to two years of steady drug delivery.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.